HEALTH AND BUSINESS

Implantable medical devices, Conflavoro PMI Sanità: "New costs and fines of up to €113.200"

The association calls for amendments to the National Registry bill: the focus is on disclosure requirements, responsibilities, and charges for distributors.
Listen to this article Play the audio version
Listen
Loading ...

ROME. Conflavoro PMI Sanità is raising the alarm regarding bill S.1875, approved by the Senate on October 7, which establishes the National Register of Implantable Medical Devices. The association's concerns include new reporting requirements, penalties, and organizational costs for businesses, particularly SME distributors.

"Penalties ranging from €11.300 to €113.200 are envisaged, without adequately distinguishing between serious violations, correctable errors, and delays in hospital communications," says Gennaro Broya de Lucia, president of Conflavoro PMI Sanità. The risk, he adds, is "imposing an excessive workload on companies, doctors, nurses, and administrative staff."

Managing devices such as stents, orthopedic implants, and TAVI valves requires distinguishing between delivery, sale, and implantation. While the distributor manages material movements, it is the hospital that confirms their actual clinical use. Without interoperable IT systems, the association warns, the Registry could increase manual entry, data reconciliation, and disputes.

Another issue concerns information management: according to Conflavoro PMI Sanità, ownership, access, and responsibility must be clarified, protecting commercial data and preventing suppliers from being held liable for clinical information they neither produce nor can certify.

The association also notes that the impact assessment considers 440 manufacturers, without a separate assessment of the impact on distributors. "According to our estimates, over 1.500 distributors operate in the Italian market. This is a component of the supply chain that cannot be overlooked when assessing costs and compliance requirements," Broya de Lucia emphasizes.

Also of concern is the funding of the Registry through the Fund supported by the 0,75% contribution on sales to the National Health Service, which has already been contested by the association.

"Businesses would find themselves having to finance a system that requires them to invest further in staff, software, and compliance management, placing an especially heavy burden on smaller businesses," the president states.

Conflavoro PMI Sanità is therefore calling for corrections to be made during the parliamentary process, starting with a review of the sanctions. The association also calls for implementing decrees to ensure system interoperability, specific rules for materials on consignment, responsibilities commensurate with the data actually available, and a gradual introduction of the Register.

"We ask the Ministry to directly involve representatives of SME distributors. The new rules must take into account the actual functioning of the supply chain and the costs that will be borne by businesses and hospital staff," concludes Broya de Lucia.

All Rights Reserved
Follow Chronicles of Campania Official channels


Breaking News

Read all the news

Top News